HOPE Center News

Read about the latest publications, achievements and more from the College's faculty members!

The opportunities in the program are endless and I have the freedom to explore many different routes without being tied to one area.

PharmD students Jennifer Weisbrod, Chloe Grace Rose, and Joshua Kessler achieved much in HOPE Center's first APPE rotation.

At least 15 Arizona health insurance companies contacted in study cover Valley Fever diagnostic tests, helping to increase early diagnosis rates.

A new school year and new leadership has members of the UArizona ISPOR (International Society of Pharmacoeconomics and Outcomes Research) student chapter thinking about the past year and setting goals for the future.

HOPE Center highlights Dr. Rhys Axon's research and teaching accomplishments.

Two new studies show economic benefits of switching from pegfilgrastim to biosimilars to prevent or treat chemotherapy-induced febrile neutropenia.

Overall results showed that once-daily extended-release tacrolimus tablets were incrementally more costly and more effective than twice-daily immediate-release therapy among Hispanic and Black kidney transplant recepients.

Wishing all the best to our newest graduates from the Health and Pharmaceutical Outcomes doctoral program.

Recognizing three doctoral students from the Health and Pharmaceutical Outcomes program for their excellence in research and outstanding academic success.

Adherence to noninsulin antidiabetic medications was associated with more outpatient and fewer inpatient visits, as well as lower total expenditures compared with nonadherence.

Results warrant future consideration towards implementing advanced clinical decision support systems (CDSS) with appropriate systematic training programs in other pharmacy settings.

A recent HOPE Center study estimated total lifetime costs of valley fever in Arizona at $736 million.